Pneumococcal Immunization: From Policy to Practice

Schwartz, Benjamin; Breiman, Robert F.
September 1990
JAMA: Journal of the American Medical Association;9/5/90, Vol. 264 Issue 9, p1154
Academic Journal
Editorial. Deals with the low utilization of pneumococcal vaccines targeted for adults in the U.S. Factors behind the lack of use of pneumococcal vaccines; Strategies that can be adopted to increase utilization of pneumococcal vaccines; Cost benefits of immunization.


Related Articles

  • Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C. Park, In H.; Moore, Matthew R.; Treanor, John J.; Pelton, Stephen I.; Pilishvili, Tamara; Beall, Bernard; Shelly, Mark A.; Mahon, Barbara E.; Nahm, Moon H. // Journal of Infectious Diseases;12/15/2008, Vol. 198 Issue 12, p1818 

    Background. Because classic pneumococcal serotyping methods cannot distinguish between serotypes 6A and 6C, the effects of pneumococcal vaccines against serotype 6C are unknown. Pneumococcal vaccines contain serotype 6B but not serotypes 6A and 6C. Methods. We used a phagocytic killing assay to...

  • Child vaccine delayed by six months.  // Pulse;6/1/2006, Vol. 66 Issue 22, p2 

    The article reports that general practitioner negotiators have warned that pneumococcal vaccination will not be introduced into the childhood schedule in Great Britain until the end of 2006 at the earliest. The warning is confirmation that the vaccine will be delayed from its proposed...

  • GP Business: Ensuring pneumococcal and flu jabs work for you. Summerton, Nick // GP: General Practitioner;10/1/2004, p49 

    This article states that direct enhanced services (DES) rules encourage good immunization programs. In primary care pneumococcal immunization has always been the poor relation to influenza immunization. Although both flu and pneumococcal diseases are common causes of hospitalization and death in...

  • Are Anticapsular Antibodies the Primary Mechanism of Protection against Invasive Pneumococcal Disease? Lipsitch, Marc; Whitney, Cynthia G.; Zell, Elizabeth; Kaijalainen, Tarja; Dagan, Ron; Malley, Richard // PLoS Medicine;Jan2005, Vol. 2 Issue 1, p62 

    Background Antibody to capsular polysaccharide has been the basis of several vaccines that offer protection against invasive disease from Streptococcus pneumoniae. The success of such vaccines has led to the inference that natural protection against invasive pneumococcal disease is largely...

  • New children's vaccines, new direction. Kassianos, George // GP: General Practitioner;1/12/2007, p30 

    The article focuses on issues related to the introduction of routine immunization of infants against pneumococcal disease in Great Britain. The new immunization schedule was announced on June 12, 2006. One of the problems of introducing a new vaccine is how to fit another vaccine into the...

  • General considerations.  // WHO Technical Report Series;2004, Issue 927, p66 

    The article focuses on polysaccharide vaccines for infections caused by Streptococcus pneumoniae, which are responsible for substantial morbidity and mortality, commonly on children and the elderly. Pneumociccus are classified based on chemical and serological distinct capsular polysaccharides....

  • Prevenar joins schedule in June. Reid, Stewart // New Zealand Doctor;5/7/2008, p17 

    The article focuses on the use of Prevenar as vaccine. According to the author, starting June 1, 2008 heptavalent conjugate pneumococcal vaccine Prevenar will be part of the New Zealand routine immunization schedule. The immunization will have a four-dose schedule with doses at six weeks, three,...

  • Pneumococcal vaccine protective in older patients.  // Geriatrics;Mar1991, Vol. 46 Issue 3, p19 

    The article reports that in an on-going control study of the protective effect of pneumatically vaccine in older adults, the vaccine appears to offer substantial protection. The study identified 744 adults who had systemic pneumatically infections, as documented by isolation of Streptococcus...

  • Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children. Pichichero, Michael E.; Casey, Janet R. // JAMA: Journal of the American Medical Association;10/17/2007, Vol. 298 Issue 15, p1772 

    This article presents a study seeking to address concerns that a multiresistant strain of pneumococcal bacteria has surfaced in the U.S. and is not covered by the 7-valent conjugate vaccine approved by the Food & Drug Administration (FDA). The vaccine had a significant impact on stopping...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics